Affymetrix's market focus

Affymetrix Inc., (Santa Clara, Calif.) leader of a consortium that last week was awarded a $31.5 million government grant to develop miniaturized DNA diagnostic systems, will focus on building high-tech tools for biomedical research and leave the development of clinical applications to its customers.

Affymetrix, a subsidiary of Affymax N.V. (AFMXF), uses photolithographic techniques and solid phase chemical synthesis to create arrays of DNA

Read the full 630 word article

How to gain access

Continue reading with a
two-week free trial.